Chemoinformaics analysis of p-Mentha-1(7),8(10)-dien-9-ol
| Molecular Weight | 152.237 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -1.515 | nHRing | 0 |
| Solubility: LogP | 1.834 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.602 |
| Synth | 3.375 |
| Natural Product Likeliness | 2.405 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.491 |
| MDCK | 0.0000114 |
| BBB | 0.989 |
| PPB | 0.530993 |
| VDSS | 0.935 |
| FU | 0.57781 |
| CYP1A2-inh | 0.115 |
| CYP1A2-sub | 0.333 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.188 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.099 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.826 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.262 |
| CL | 7.683 |
| T12 | 0.723 |
| hERG | 0.016 |
| Ames | 0.706 |
| ROA | 0.033 |
| SkinSen | 0.347 |
| Carcinogencity | 0.903 |
| EI | 0.988 |
| Respiratory | 0.275 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.929863 |